New drug offers new hope for AMD sufferers
Washington: A new drug holds promise for those with age-related macular degeneration, which is the leading cause of vision loss and blindness in older adults.
A team of ophthalmologists at the University of Iowa has shown that the drug, Eylea, can ease leaking and vision problems for wet AMD patients.
In a study involving 31 AMD patients at the UI Hospitals and Clinics, researchers report that half of the eyes treated with Eylea had reduced fluid after three monthly injections.
Moreover, in some cases subsequent bimonthly injections with Eylea were deemed as effective as monthly injections of Avastin and Lucentis over a similar time period, meaning fewer visits by patients and less cost.
The patients who tried out Eylea were 79 years old on average and all had undergone eye injections with Avastin and Lucentis, some dozens of times.
The UI study was a pilot, designed to test Eylea`s effectiveness in a small cohort for six months.
The research was funded by the National Institutes of Health.
More from India
More from World
More from Sports
More from Entertaiment
- DNA: Analysis of public pulse through survey by Zee News on Bihar elections
- Hotels selling beef should be demolished: Azam Khan
- DNA: End of ISIS? Vladimir Putin to send 1,50,000 soldiers to Syria
- Russia surprises America with accord on battling ISIS
- Panel discussion on Muslim vote bank in Bihar elections
- Neither Dadri nor Babri: India is 'Muslim woman delivering 'Ganesha' inside temple'
- Hindu girl embraces Islam to marry Shahi Imam Bukhari's son?
- Pakistan take note! Indian military 5th deadliest in the world
- Lalu Prasad Yadav debuts on Dubsmash, mocks PM Narendra Modi – Watch video
- India vs South Africa: How cricket fraternity reacted to crowd's disgraceful behaviour at Cuttack